PUGNAc and GlcN treatments also result in improved cardiac function and organ perfusion and reduced circulating levels of IL-6 and TNF-α in association with increased O-GlcNAc protein modification in the heart, liver, and kidney of rats subjected to trauma-hemorrhage [31]–[33]. This evidence concerns the gene TNF and hemorrhage.